MAUDE Adverse Event Report: DEPUY CMW - 9610921 DEPUY1 GENTAMICIN CEMENT 40G; BONE CEMENT : BONE CEMENT

Model Number 5450-31-500

Device Problem Loss of or Failure to Bond (1068)

Patient Problems Pain (1994); Loss of Range of Motion (2032); Distress (2329); Deformity/ Disfigurement (2360); Ambulation Difficulties (2544)

Event Date 02/04/2019

Event Type  Injury  

Manufacturer Narrative

Product complaint #: (b)(4).Dmf# - (b)(4), trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form - powder, strength 1.0g active in our cements.Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.

Event Description

Attune knee claim record received.Claim record alleges personal injuries, pain, anguish, disfigurement, physical impairment and loosening of the tibial component at the cement to implant interface.Depuy cement was used.All of the depuy attune knee and bone cement products were removed and replaced with competitor products.On (b)(6) 2015, the patient had a right total knee arthroplasty to address right degenerative joint disease with varus deformity.Depuy components including depuy patella depuy cement x2 were used during this procedure.(sticker page 8 of 13).On (b)(6) 2019, the patient was revised to address failed right total knee arthroplasty.The indications for surgery included pain and limited motion.Loosening of the tibial tray was noted at the cement/implant interface.The femoral component was noted to be well fixed, but still revised.Doi: (b)(6) 2015, dor: (b)(6) 2019, right knee.

Manufacturer Narrative

Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.

• Brand Name: DEPUY1 GENTAMICIN CEMENT 40G
• Type of Device: BONE CEMENT : BONE CEMENT
• Manufacturer (Section D): DEPUY CMW - 9610921; cornford rd; blackpool FY4 4 QQ; UK FY4 4QQ
• MDR Report Key: 11494467
• MDR Text Key: 240041471
• Report Number: 1818910-2021-05154
• Device Sequence Number: 1
• Product Code: MBB
• UDI-Device Identifier: 10603295174264
• UDI-Public: 10603295174264
• Combination Product (y/n): Y
• PMA/PMN Number: K081163
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: consumer,other
• Type of Report: Initial,Followup
• Report Date: 05/09/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 03/16/2021
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 10/31/2017
• Device Model Number: 5450-31-500
• Device Catalogue Number: 545031500
• Device Lot Number: 7991037
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 05/04/2021
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Treatment: ATTUNE MEDIAL ANAT PAT 35MM; ATTUNE PS FEM RT SZ 8 CEM; ATTUNE PS RP INSRT SZ 8 10MM; ATTUNE RP TIB BASE SZ 7 CEM; DEPUY1 GENTAMICIN CEMENT 40G; DEPUY1 GENTAMICIN CEMENT 40G; ATTUNE MEDIAL ANAT PAT 35MM; ATTUNE PS FEM RT SZ 8 CEM; ATTUNE PS RP INSRT SZ 8 10MM; ATTUNE RP TIB BASE SZ 7 CEM; DEPUY1 GENTAMICIN CEMENT 40G; DEPUY1 GENTAMICIN CEMENT 40G
• Patient Outcome(s): Required Intervention
• Patient Age: 54 YR